Pharmaceutical

Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies

Porton Advanced Solutions and EVA Pharma have signed an MoU to enhance the development capabilities for CAR T-cell therapies.

Jun 27, 2025 - 06:00
Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies
Porton Advanced Solutions and EVA Pharma have signed an MoU to enhance the development capabilities for CAR T-cell therapies.
Read the original article

Tags:

Previous Article

New Study Uncovers How Common Mutation Drives Prostate Cancer Development

Next Article

Vor Bio back from brink with autoimmune drug deal rising to $4bn

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Big tech meets biotech: Recursion and the AI gold rush in pharma 

Big tech meets biotech: Recursion and the AI gold rush ...

Mar 19, 2025

China NMPA grants IND clearance for Fermion’s TYK2 JH2 inhibitor

China NMPA grants IND clearance for Fermion’s TYK2 JH2 ...

Feb 6, 2024

STAT+: A junior scientist. A prominent oncologist. Now, a clash at MD Anderson over who gets research credit

STAT+: A junior scientist. A prominent oncologist. Now,...

Feb 9, 2024